Peripheral monocytes and soluble biomarkers in autoimmune encephalitis

Area of Science:

• Neuroimmunology
• Innate Immunity
• Central Nervous System Inflammation

Background:

• Autoimmune encephalitis (AE) can cause lasting neurological deficits.
• The role of innate immunity in AE pathogenesis is unclear.
• Investigating innate immune markers may reveal AE's long-term impact.

Purpose of the Study:

• To explore the involvement of peripheral monocytes and serum cytokines in AE.
• To correlate innate immune profiles with AE outcomes.

Main Methods:

• Cross-sectional study of 40 AE patients and 28 healthy controls.
• Flow cytometry to analyze peripheral blood monocyte subsets.
• ELISA to quantify serum cytokine levels (e.g., IL-6).

Main Results:

• AE patients showed expanded CD14+CD16+ pro-inflammatory monocytes compared to controls.
• Elevated serum IL-6 levels were observed in the AE cohort.
• These alterations were most pronounced in anti-LGI-1 antibody-mediated AE.

Conclusions:

• Increased peripheral CD14+CD16+ monocytes and serum IL-6 suggest a persistent pro-inflammatory state in AE.
• These findings align with changes seen in other neuroinflammatory conditions.
• Innate immune dysregulation may contribute to poor long-term cognitive outcomes in AE.